Aurora Cannabis

Aurora Cannabis develops, manufactures, and distributes medical and consumer cannabis products, with an emphasis on science-based formulation and quality control. The company operates across regulated cultivation, manufacturing and production, quality assurance, product development, research, and supply chain, and sells into both the pharmaceuticals and healthcare sector and the consumer market. Products and brands are available in Canada, Europe, Australia, and New Zealand.

The brand portfolio comprises seven names: Aurora, MedReleaf, CanniMed, Whistler, Pedanios, Greybeard, and CraftPlant, spanning the company's medical and consumer lines. The organisation's stated mission is "Opening the World to Cannabis", and it cites rigorous scientific expertise, manufacturing excellence, and product quality as operating priorities, together with close support for patients and customers.

Operations are international in scope and cover manufacturing, quality assurance, supply chain, product development, medical and consumer sales, science, and corporate functions. The company states that it offers competitive compensation, bonuses, savings plans, flexible benefit plans, health or personal spending accounts, medical-cannabis coverage for employees, and employee volunteer opportunities, within a culture it describes as diverse and inclusive across its markets.